Source: BioPortfolio

Juniper Pharmaceuticals: Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals Inc.

Catalent Inc. NYSECTLT Catalent the leading global provider of advanced delivery technologies and development solutions for drugs biologics and consumer health products today announced the successful completion of the previously ann...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Alicia Secor's photo - President & CEO of Juniper Pharmaceuticals

President & CEO

Alicia Secor

CEO Approval Rating

78/100

Read more